Modus Therapeutics Holding AB (publ) MODTX.ST
MODTX.ST
Modus Therapeutics Holding AB (publ) 2CUREX.ST
2cureX AB (publ) EXPRS2.ST
ExpreS2ion Biotech Holding AB (publ) AINO.ST
Aino Health AB (publ) ORTI-B.ST
Ortivus AB (publ) QLIFE.ST
Qlife Holding AB (publ) FLUI.ST
Fluicell AB (publ) EPIS-B.ST
Episurf Medical AB (publ) STABL.ST
Stayble Therapeutics AB (publ) ACOU.ST
AcouSort AB (publ)
Modus Therapeutics Holding AB (publ) 2CUREX.ST
2cureX AB (publ) EXPRS2.ST
ExpreS2ion Biotech Holding AB (publ) AINO.ST
Aino Health AB (publ) ORTI-B.ST
Ortivus AB (publ) QLIFE.ST
Qlife Holding AB (publ) FLUI.ST
Fluicell AB (publ) EPIS-B.ST
Episurf Medical AB (publ) STABL.ST
Stayble Therapeutics AB (publ) ACOU.ST
AcouSort AB (publ)
Performance
| Periode | MODTX.ST | 2CUREX.ST | EXPRS2.ST | AINO.ST | ORTI-B.ST | QLIFE.ST | FLUI.ST | EPIS-B.ST | STABL.ST | ACOU.ST |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -67.19 % | 152.53 % | -4.02 % | 3.52 % | -23.47 % | 3.37 % | 9.24 % | -59.52 % | -54.92 % | -27.53 % |
| YTD | -76.14 % | 273.75 % | -23.69 % | -14.17 % | -22.41 % | 3.37 % | -40.86 % | -65.42 % | -62.07 % | -74.71 % |
| 1Y | -70.42 % | 169.37 % | -46.12 % | 71.67 % | -30.12 % | -11.16 % | -46.63 % | -66.84 % | -65.35 % | -77.92 % |
| 3Y | -79.90 % | -82.97 % | -95.95 % | -11.84 % | -78.03 % | -99.98 % | -98.65 % | -97.38 % | -94.42 % | -82.24 % |
| 5Y | -92.00 % | -90.32 % | -96.05 % | -77.77 % | -78.89 % | -99.99 % | -99.54 % | -97.79 % | -97.44 % | -86.20 % |
| 10Y | -92.00 % | -80.35 % | -91.20 % | -98.28 % | -66.60 % | -99.99 % | -99.76 % | -99.57 % | -97.14 % | -86.20 % |
| From the beginning | -92.00 % | -80.35 % | -91.20 % | -98.28 % | -96.86 % | -99.99 % | -99.76 % | -99.30 % | -97.14 % | -86.20 % |